Publikationer

Væth, S., Væth, M., Andersen, H., Christensen, R. & Jensen, U. B. (2017). Charcot-Marie-Tooth disease in Denmark: a nationwide register-based study of mortality, prevalence and incidence. BMJ Open, 7(11), [e018048]. https://doi.org/10.1136/bmjopen-2017-018048

Væth, M., Skriver, M. V. & Støvring, H. (2018). The impact of proportional changes in age-specific mortality on life expectancy when mortality is a log-linear function of age. Demographic Research, 39, 671-684. [23]. https://doi.org/10.4054/DemRes.2018.39.23

Vámosi, M., Lauberg, A., Borregaard, B., Christensen, A. V., Thrysoee, L., Rasmussen, T. B., Ekholm, O., Juel, K. & Berg, S. K. (2020). Patient-reported outcomes predict high readmission rates among patients with cardiac diagnoses. Findings from the DenHeart study. International Journal of Cardiology, 300, 268-275. https://doi.org/10.1016/j.ijcard.2019.09.046

Vrieling, A., Bueno-de-Mesquita, H. B., Boshuizen, H. C., Michaud, D. S., Severinsen, M. T., Overvad, K., Olsen, A., Tjønneland, A., Clavel-Chapelon, F., Boutron-Ruault, M-C., Kaaks, R., Rohrmann, S., Boeing, H., Nöthlings, U., Trichopoulou, A., Moutsiou, E., Dilis, V., Palli, D., Krogh, V. ... Riboli, E. (2010). Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 126(10), 2394-403. https://doi.org/10.1002/ijc.24907

Voutchkova, D. D., Schullehner, J., Knudsen, N. N., Jørgensen, L. F., Ersbøll, A. K., Kristiansen, S. M. & Hansen, B. (2015). Exposure to selected geogenic trace elements (I, Li, and Sr) from drinking water in Denmark. Geosciences, 5(1), 45-66. https://doi.org/10.3390/geosciences5010045

Voss, A. B., Green, A. & Junker, P. (1999). Systemisk lupus erythematosus i Fyns Amt: En epidemiologisk undersøgelse. Ugeskrift for Laeger, 161(25), 3837-3840.

Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., Aulchenko, Y. S., Thorleifsson, G., McCulloch, L. J., Ferreira, T., Grallert, H., Amin, N., Wu, G., Willer, C. J., Raychaudhuri, S., McCarroll, S. A., Langenberg, C. ... MAGIC investigators (2010). Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics, 42(7), 579-89. https://doi.org/10.1038/ng.609

Voight, B. F., Peloso, G. M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M. K., Hindy, G., Hólm, H., Ding, E. L., Johnson, T., Schunkert, H., Samani, N. J., Clarke, R., Hopewell, J. C., Thompson, J. F., Li, M., Thorleifsson, G., Newton-Cheh, C., Musunuru, K. ... Kathiresan, S. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 380(9841), 572-80. https://doi.org/10.1016/S0140-6736(12)60312-2

Vogel, U., Olsen, A. V., Håkan, W., Overvad, K., Tjønneland, A. & Nexø, B. A. (2005). Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect Prev., 29(3), 209-214.

Vogel, U. B., Laros, I., Jacobsen, N. R., Thomsen, B. L., Bak, H., Olsen, A. V., Bukowy, Z., Wallin, E. H. R., Overvad, K., Tjønneland, A., Nexø, B. A. & Raaschou-Nielsen, O. L. (2004). Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 546(1-2), 65-74.

Vogel, U., Nexø, B. A., Olsen, A. V., Thomsen, B., Jacobsen, N. R., Wallin, H., Overvad, K. & Tjønneland, A. (2003). No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 12, 170-171.

Vogel, U., Olsen, A. V., Wallin, H., Overvad, K., Tjønneland, A. & Nexø, B. A. (2004). No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 13(10), 1680-1681.

Vogel, U., Daneshvar, B., Autrup, H., Risom, L., Weimann, A., Poulsen, H. E., Møller, P., Loft, S., Wallin, H. & Dragsted, L. O. (2003). Effect of increased intake of dietary animal fat and fat energy on oxidative damage, mutation frequency, DNA adduct level and DNA repair in rat colon and liver. Free Radical Research, 37(9), 947-956.

Vogel, I., Thorsen, P., Flyvbjerg, A. & Grønbæk, H. (2003). Albumin in vaginal secretions is a marker of infection in early pregnancy. International Journal of Gynecology & Obstetrics, 83(3), 307-308. https://doi.org/10.1016/S0020-7292(03)00268-6

Vogel, I., Grønbæk, H., Uldbjerg, N. & Forman, A. (2004). Amphotericin B and neomycin interfere with the effects of human relaxin-2 on fetal membranes and isolated myometrium. Basic Clin. Pharmacol. Toxicol., 94, 144-150.

Vogel, I., Thorsen, P., Hundborg, H. H. & Uldbjerg, N. (2006). Prediction af preterm delivery using changes in serum relaxin in low risk pregnancies. European Journal of Obstetrics & Gynecology and Reproductive Biology, 128, 113 - 118.

Vogel, I., Kesmodel, U., Rasmussen, S., Langhoff-Roos, J. & Jacobsson, B. G. (2006). Preterm delivery in primiparous women at low risk: Preterm birth or delivery? Study authors suggest new terms. B M J, 332, 1094.

Vogel, I., Grønbaek, H., Uldbjerg, N. & Forman, A. (2004). The influence of amphotericin B and neomycin on the effect of human relaxin-2 on foetal membranes and isolated myometrium. Basic & Clinical Pharmacology & Toxicology, 94(3), 144-50. https://doi.org/10.1111/j.1742-7843.2004.pto940308.x

Vogel, I., Petersen, A., Petersen, L. K., Helmig, R. B., Oxlund, H. & Uldbjerg, N. (2004). Biphasic effect of relaxin, inhibitable by a collagenase inhibitor, on the strength of human fetal membranes. In Vivo, 18(5), 581-4.

Vogel, I., Grove, J., Thorsen, P., Moestrup, S. K., Uldbjerg, N. & Møller, H. J. (2005). Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery. B J O G, 112(6), 737-42. https://doi.org/10.1111/j.1471-0528.2005.00557.x

Vogel, I., Thorsen, P., Hundborg, H. H. & Uldbjerg, N. (2006). Prediction of preterm delivery using changes in serum relaxin in low risk pregnancies. European Journal of Obstetrics & Gynecology and Reproductive Biology, 128(1-2), 113-8. https://doi.org/10.1016/j.ejogrb.2005.11.002

Vogel, I., Goepfert, A. R., Thorsen, P., Skogstrand, K., Hougaard, D. M., Curry, A. H., Cliver, S. & Andrews, W. W. (2007). Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth. Journal of Reproductive Immunology, 75(2), 133-40. https://doi.org/10.1016/j.jri.2007.02.008

Vogel, I., Thorsen, P., Jeune, B., Jacobsson, B., Ebbesen, N., Arpi, M., Bremmelgaard, A. & Møller, B. R. (2006). Acquisition and elimination of bacterial vaginosis during pregnancy: a Danish population-based study. Infectious Diseases in Obstetrics and Gynecology, 2006, [94646]. https://doi.org/10.1155/IDOG/2006/94646

Vogel, I., Lyngbye, T., Nielsen, A., Pedersen, S. & Hertz, J. M. (2009). Pallister-Killian syndrome in a girl with mild developmental delay and mosaicism for hexasomy 12p. American Journal of Medical Genetics. Part A, 149A(3), 510-4. https://doi.org/10.1002/ajmg.a.32681

Vogel, I., Hollegaard, M. V., Hougaard, D. M., Thorsen, P. & Grove, J. (2009). Polymorphisms in the promoter region of relaxin-2 and preterm birth: involvement of relaxin in the etiology of preterm birth. In Vivo, 23(6), 1005-9.

Vogel, I., Glavind-Kristensen, M., Thorsen, P., Armbruster, F. P. & Uldbjerg, N. (2002). S-relaxin as a predictor of preterm delivery in women with symptoms of preterm labour. B J O G, 109(9), 977-82.

Vogel, I., Thorsen, P., Curry, A., Sandager, P. & Uldbjerg, N. (2005). Biomarkers for the prediction of preterm delivery. Acta Obstetricia et Gynecologica Scandinavica, 84(6), 516-25. https://doi.org/10.1111/j.0001-6349.2005.00771.x

Vogel, I., Goepfert, A. R., Møller, H. J., Cliver, S., Thorsen, P. & Andrews, W. W. (2006). Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery. American Journal of Obstetrics and Gynecology, 195(1), 208-14. https://doi.org/10.1016/j.ajog.2005.12.009

Vogel, I., Thorsen, P., Hogan, V. K., Schieve, L. A., Jacobsson, B. & Ferre, C. D. (2006). The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstetricia et Gynecologica Scandinavica, 85(7), 778-85. https://doi.org/10.1080/00016340500442423

Vogel, I., Grønbaek, H., Thorsen, P. & Flyvbjerg, A. (2004). Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy. In Vivo, 18(1), 37-41.

Vogel, U., Jensen, M. K., Due, K. M., Rimm, E. B., Wallin, H., Nielsen, M. R. S., Pedersen, A-P. T., Tjønneland, A. & Overvad, K. (2011). The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis, 219(1), 200-204. https://doi.org/10.1016/j.atherosclerosis.2011.06.018

Vogel, U., Olsen, A., Wallin, H., Overvad, K., Tjønneland, A. & Nexø, B. A. (2004). No association between GPX Pro198Leu and risk of basal cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 13(8), 1412-3.

Viuff, A-C. F., Pedersen, L. H., Kyng, K., Staunstrup, N. H., Børglum, A. & Henriksen, T. B. (2016). Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review. Clinical Epigenetics (Print), 8(1). https://doi.org/10.1186/s13148-016-0262-x

Viuff, M. H., Berglund, A., Juul, S., Andersen, N. H., Stochholm, K. & Gravholt, C. H. (2020). Sex hormone replacement therapy in Turner Syndrome - impact on morbidity and mortality. The Journal of clinical endocrinology and metabolism, 105(2), [dgz039]. https://doi.org/10.1210/clinem/dgz039

Vistisen, H. T., Garde, A. H., Frydenberg, M., Christiansen, P., Hansen, Å. M., Hansen, J., Bonde, J. P. E. & Kolstad, H. A. (2017). Short-term effects of night shift work on breast cancer risk; a cohort study of payroll data. Scandinavian Journal of Work, Environment & Health, 43(1), 59-67. https://doi.org/10.5271/sjweh.3603

Vistisen, D., Witte, D. R., Brunner, E. J., Kivimäki, M., Tabák, A., Jørgensen, M. E. & Færch, K. (2018). Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study. Diabetes Care, 41(4), 899-906. https://doi.org/10.2337/dc17-2530

Vistisen, D., Kivimäki, M., Perreault, L., Hulman, A., Witte, D. R., Brunner, E. J., Tabák, A., Jørgensen, M. E. & Færch, K. (2019). Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study. Diabetologia, 62(8), 1385-1390. https://doi.org/10.1007/s00125-019-4895-0

Vistisen, D., Andersen, G. S., Hulman, A., Persson, F., Rossing, P. & Jørgensen, M. E. (2019). Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney functiond even without albuminuria. Diabetes Care, 42(10), 1886-1894. https://doi.org/10.2337/dc19-0349